Literature DB >> 30145242

Host functions used by hepatitis B virus to complete its life cycle: Implications for developing host-targeting agents to treat chronic hepatitis B.

Bidisha Mitra1, Roshan J Thapa2, Haitao Guo3, Timothy M Block4.   

Abstract

Similar to other mammalian viruses, the life cycle of hepatitis B virus (HBV) is heavily dependent upon and regulated by cellular (host) functions. These cellular functions can be generally placed in to two categories: (a) intrinsic host restriction factors and innate defenses, which must be evaded or repressed by the virus; and (b) gene products that provide functions necessary for the virus to complete its life cycle. Some of these functions may apply to all viruses, but some may be specific to HBV. In certain cases, the virus may depend upon the host function much more than does the host itself. Knowing which host functions regulate the different steps of a virus' life cycle, can lead to new antiviral targets and help in developing novel treatment strategies, in addition to improving a fundamental understanding of viral pathogenesis. Therefore, in this review we will discuss known host factors which influence key steps of HBV life cycle, and further elucidate therapeutic interventions targeting host-HBV interactions.
Copyright © 2018. Published by Elsevier B.V.

Entities:  

Keywords:  Antiviral agents; Direct acting antiviral agents; Hepatitis; Hepatitis B virus (HBV); Host targeting agents; Liver; Virus-host interaction

Mesh:

Substances:

Year:  2018        PMID: 30145242      PMCID: PMC6193490          DOI: 10.1016/j.antiviral.2018.08.014

Source DB:  PubMed          Journal:  Antiviral Res        ISSN: 0166-3542            Impact factor:   5.970


  197 in total

Review 1.  Present and future therapies of hepatitis B: From discovery to cure.

Authors:  T Jake Liang; Timothy M Block; Brian J McMahon; Marc G Ghany; Stephan Urban; Ju-Tao Guo; Stephen Locarnini; Fabien Zoulim; Kyong-Mi Chang; Anna S Lok
Journal:  Hepatology       Date:  2015-10-27       Impact factor: 17.425

2.  MicroRNA-dependent regulation of DNA methyltransferase-1 and tumor suppressor gene expression by interleukin-6 in human malignant cholangiocytes.

Authors:  Chiara Braconi; Nianyuan Huang; Tushar Patel
Journal:  Hepatology       Date:  2010-03       Impact factor: 17.425

3.  Hepatitis B Virus Covalently Closed Circular DNA Formation in Immortalized Mouse Hepatocytes Associated with Nucleocapsid Destabilization.

Authors:  Xiuji Cui; Ju-Tao Guo; Jianming Hu
Journal:  J Virol       Date:  2015-06-17       Impact factor: 5.103

4.  Incorporation of eukaryotic translation initiation factor eIF4E into viral nucleocapsids via interaction with hepatitis B virus polymerase.

Authors:  Seahee Kim; Haifeng Wang; Wang-Shick Ryu
Journal:  J Virol       Date:  2010-01       Impact factor: 5.103

5.  Regulation of hepatitis B virus infection by Rab5, Rab7, and the endolysosomal compartment.

Authors:  Alina Macovei; Catalina Petrareanu; Catalin Lazar; Paula Florian; Norica Branza-Nichita
Journal:  J Virol       Date:  2013-03-27       Impact factor: 5.103

6.  Transactivation of the hepatitis B virus core promoter by the nuclear receptor FXRalpha.

Authors:  Christophe Ramière; Caroline Scholtès; Olivier Diaz; Vinca Icard; Laure Perrin-Cocon; Mary-Anne Trabaud; Vincent Lotteau; Patrice André
Journal:  J Virol       Date:  2008-09-03       Impact factor: 5.103

7.  Promoter-specific transactivation of hepatitis B virus transcription by a glutamine- and proline-rich domain of hepatocyte nuclear factor 1.

Authors:  A K Raney; A J Easton; D R Milich; A McLachlan
Journal:  J Virol       Date:  1991-11       Impact factor: 5.103

8.  Myristylation of the large surface protein is required for hepatitis B virus in vitro infectivity.

Authors:  V Bruss; J Hagelstein; E Gerhardt; P R Galle
Journal:  Virology       Date:  1996-04-15       Impact factor: 3.616

9.  A kinase chaperones hepatitis B virus capsid assembly and captures capsid dynamics in vitro.

Authors:  Chao Chen; Joseph Che-Yen Wang; Adam Zlotnick
Journal:  PLoS Pathog       Date:  2011-11-17       Impact factor: 6.823

10.  Alpha-interferon suppresses hepadnavirus transcription by altering epigenetic modification of cccDNA minichromosomes.

Authors:  Fei Liu; Matthew Campagna; Yonghe Qi; Xuesen Zhao; Fang Guo; Chunxiao Xu; Sichen Li; Wenhui Li; Timothy M Block; Jinhong Chang; Ju-Tao Guo
Journal:  PLoS Pathog       Date:  2013-09-12       Impact factor: 6.823

View more
  27 in total

Review 1.  Host-Directed Antiviral Therapy.

Authors:  Naveen Kumar; Shalini Sharma; Ram Kumar; Bhupendra N Tripathi; Sanjay Barua; Hinh Ly; Barry T Rouse
Journal:  Clin Microbiol Rev       Date:  2020-05-13       Impact factor: 26.132

Review 2.  Hepatitis B virus cccDNA: Formation, regulation and therapeutic potential.

Authors:  Yuchen Xia; Haitao Guo
Journal:  Antiviral Res       Date:  2020-05-22       Impact factor: 5.970

3.  Hepatitis B Virus Precore Protein p22 Inhibits Alpha Interferon Signaling by Blocking STAT Nuclear Translocation.

Authors:  Bidisha Mitra; Jinyu Wang; Elena S Kim; Richeng Mao; Minhui Dong; Yuanjie Liu; Jiming Zhang; Haitao Guo
Journal:  J Virol       Date:  2019-06-14       Impact factor: 5.103

Review 4.  Novel therapeutic strategies for chronic hepatitis B.

Authors:  Sandra Phillips; Ravi Jagatia; Shilpa Chokshi
Journal:  Virulence       Date:  2022-12       Impact factor: 5.428

5.  Characterization of the Termini of Cytoplasmic Hepatitis B Virus Deproteinated Relaxed Circular DNA.

Authors:  Dawei Cai; Ran Yan; Jerry Z Xu; Hu Zhang; Sheng Shen; Bidisha Mitra; Alexander Marchetti; Elena S Kim; Haitao Guo
Journal:  J Virol       Date:  2020-12-09       Impact factor: 5.103

6.  DNA Polymerase alpha is essential for intracellular amplification of hepatitis B virus covalently closed circular DNA.

Authors:  Liudi Tang; Muhammad Sheraz; Michael McGrane; Jinhong Chang; Ju-Tao Guo
Journal:  PLoS Pathog       Date:  2019-04-26       Impact factor: 6.823

7.  RNA Helicase DDX17 Inhibits Hepatitis B Virus Replication by Blocking Viral Pregenomic RNA Encapsidation.

Authors:  Richeng Mao; Minhui Dong; Zhongliang Shen; Hu Zhang; Yuanjie Liu; Dawei Cai; Bidisha Mitra; Jiming Zhang; Haitao Guo
Journal:  J Virol       Date:  2021-09-09       Impact factor: 5.103

Review 8.  Review of Lambda Interferons in Hepatitis B Virus Infection: Outcomes and Therapeutic Strategies.

Authors:  Laura A Novotny; John Grayson Evans; Lishan Su; Haitao Guo; Eric G Meissner
Journal:  Viruses       Date:  2021-06-09       Impact factor: 5.048

Review 9.  Molecular Mechanisms during Hepatitis B Infection and the Effects of the Virus Variability.

Authors:  Marina Campos-Valdez; Hugo C Monroy-Ramírez; Juan Armendáriz-Borunda; Laura V Sánchez-Orozco
Journal:  Viruses       Date:  2021-06-18       Impact factor: 5.048

10.  Orchestration of Intracellular Circuits by G Protein-Coupled Receptor 39 for Hepatitis B Virus Proliferation.

Authors:  Kaku Goto; Hironori Nishitsuji; Masaya Sugiyama; Nao Nishida; Masashi Mizokami; Kunitada Shimotohno
Journal:  Int J Mol Sci       Date:  2020-08-07       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.